Meningococcal serotype W septic arthritis: Case series in children
Corresponding Author
Aleisha J Anderson
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Department of Microbiology, Royal Children's Hospital, Melbourne, Victoria, Australia
Correspondence: Dr Aleisha Anderson, Department of Microbiology, The Royal Children's Hospital, Parkville, 50 Flemington Road, Parkville, VIC, 3052, Australia. Fax: +61 3 9345 9885; email: [email protected]
Search for more papers by this authorAsha C Bowen
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
School of Medicine, University of Western Australia, Perth, Western Australia, Australia
Search for more papers by this authorBriony Hazelton
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Department of Microbiology, PathWest Laboratory Medicine WA, Perth, Western Australia, Australia
Search for more papers by this authorMatthew O'Brien
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Search for more papers by this authorChristopher C Blyth
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
School of Medicine, University of Western Australia, Perth, Western Australia, Australia
Department of Microbiology, PathWest Laboratory Medicine WA, Perth, Western Australia, Australia
Search for more papers by this authorAnita J Campbell
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
School of Medicine, University of Western Australia, Perth, Western Australia, Australia
Search for more papers by this authorCorresponding Author
Aleisha J Anderson
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Department of Microbiology, Royal Children's Hospital, Melbourne, Victoria, Australia
Correspondence: Dr Aleisha Anderson, Department of Microbiology, The Royal Children's Hospital, Parkville, 50 Flemington Road, Parkville, VIC, 3052, Australia. Fax: +61 3 9345 9885; email: [email protected]
Search for more papers by this authorAsha C Bowen
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
School of Medicine, University of Western Australia, Perth, Western Australia, Australia
Search for more papers by this authorBriony Hazelton
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Department of Microbiology, PathWest Laboratory Medicine WA, Perth, Western Australia, Australia
Search for more papers by this authorMatthew O'Brien
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Search for more papers by this authorChristopher C Blyth
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
School of Medicine, University of Western Australia, Perth, Western Australia, Australia
Department of Microbiology, PathWest Laboratory Medicine WA, Perth, Western Australia, Australia
Search for more papers by this authorAnita J Campbell
Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
School of Medicine, University of Western Australia, Perth, Western Australia, Australia
Search for more papers by this authorConflict of interest: None declared.
References
- 1 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 30th edn. CLSI Supplement M100. Wayne: CLSI; 2020.
- 2Healthy WA. Meningococcal ACWY Vaccine. 2018. Perth, Western Australia, Australia: Department of Health Western Australia. Available from: https://healthywa.wa.gov.au/Articles/J_M/Meningococcal-vaccine [accessed 27 October 2019].
- 3 Australian Government Department of Health. Invasive Meningococcal Disease National Surveillance Report. 2017. Canberra, Australia. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/5FEABC4B495BDEC1CA25807D001327FA/$File/1Jan-31-Dec2017-Consol-Invasive-Men-W.pdf
- 4Lahra MM, Enriquez R. Australian Meningococcal Surveillance Programme annual report, 2016. Commun. Dis. Intell. Q. Rep. 2017; 41: E369–82.
- 5Porta M. A Dictionary of Epidemiology, 5th edn. Oxford: Oxford University Press; 2008.
10.1093/acref/9780195314496.001.0001 Google Scholar
- 6Vienne P, Ducos-Galand M, Guiyoule A et al. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin. Infect. Dis. 2003; 37: 1639–42.
- 7Stinson C, Burman C, Presa J, Abalos M. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol. Infect. 2020; 148: e12.
- 8Guiddir T, Gros M, Hong E et al. Unusual initial abdominal presentations of invasive meningococcal disease. Clin. Infect. Dis. 2018; 67: 1220–7.
- 9Masson-Behar V, Jacquier H, Richette P et al. Arthritis secondary to meningococcal disease: A case series of 7 patients. Medicine 2017; 96: e7573.
- 10El-Sayed AM. Treatment of early septic arthritis of the hip in children: Comparison of results of open arthrotomy versus arthroscopic drainage. J. Child. Orthop. 2008; 2: 229–37.
- 11Faye A, Mariani-Kurkdjian P, Taha MK et al. Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: A report of 5 cases. Clin. Infect. Dis. 2004; 38: 1635–7.
- 12Cabellos C, Nolla JM, Verdaguer R et al. Arthritis related to systemic meningococcal disease: 34 Years' experience. Eur. J. Clin. Microbiol. Infect. Dis. 2012; 31: 2661–6.
- 13Mowlaboccus S, Jolley KA, Bray JE et al. Clonal expansion of new penicillin-resistant clade of Neisseria meningitidis serogroup W clonal complex 11, Australia. Emerg. Infect. Dis. 2017; 23: 1364–87.
- 14van de Beek D, Cabellos C, Dzupova O et al. ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis. Clin. Microbiol. Infect. 2016; 22 (Suppl. 3): S37–62.
- 15Castillo D, Harcourt B, Jackson M, et al. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. In: L Mayer, ed. 2011 WHO Meningitis Manual. Atlanta, GA: Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention; 2011; 157–204.
- 16Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF. Antibiotic penetration into bone and joints: An updated review. Int. J. Infect. Dis. 2019; 81: 128–36.
- 17Frieden TRJH, Cono J, Richards CL, Iademarco MF. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm. Rep. 2015; 64: 60–8.
- 18 Australian Government Department of Health. Therapeutic Goods Association. Special Access Scheme. Canberra, Australia: Australian Government Department of Health. Available from: https://www.tga.gov.au/form/special-access-scheme [accessed 7 December 2020].
- 19 Australian Technical Advisory Group on Immunisation. Public Consultation on Changes to the Recommended use of Meningococcal and Haemophilus influenzae Type B Vaccines. Canberra, Australia: Australian Government Department of Health; 2018. Available from: https://consultations.health.gov.au/ohp-immunisation-branch/proposed-changes-to-meningococcal-and-hib/supporting_documents/Public%20Consultation%20Document_meningococcal%20and%20Hib%20vaccines_FINAL.pdf [accessed 27 October 2019].
